The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Baranov A.A.

Meshalkin National Medical Research Center

Krestyaninov O.V.

Meshalkin National Medical Research Center

Badoyan A.G.

Meshalkin National Medical Research Center

Khelimskii D.A.

Meshalkin National Medical Research Center

Manukyan S.N.

Meshalkin National Medical Research Center

Cydenova A.Yu.

Meshalkin National Medical Research Center

Naydenov R.A.

Meshalkin National Medical Research Center

Spiridonov A.A.

Meshalkin National Medical Research Center

Conduction disturbances after transcatheter aortic valve implantation

Authors:

Baranov A.A., Krestyaninov O.V., Badoyan A.G., Khelimskii D.A., Manukyan S.N., Cydenova A.Yu., Naydenov R.A., Spiridonov A.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2023;18(4): 19‑26

DOI: 10.17116/Cardiobulletin20231804119

Read: 3753 times

Download PDF (RU)
Contact the author
Table of contents

CONDUCTION DISTURBANCES AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
CONDUCTION DISTURBANCES AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION

To cite this article:

Baranov AA, Krestyaninov OV, Badoyan AG, et al. . Conduction disturbances after transcatheter aortic valve implantation. Russian Cardiology Bulletin. 2023;18(4):19‑26. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20231804119

 
ЭндоКард
Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cere­bral protection in transcatheter aortic valve implantation. Piro­gov Russian Journal of Surgery. 2024;(12-2):150-158
Features of pregnancy in women with pace­maker. Russian Journal of Human Reproduction. 2024;(6):124-131
Technical features of aortic valve prosthesis fixa­tion to mini­mize pressure gradient in postoperative period. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):41-44
Clinical outcomes after transcatheter aortic valve implantation in patients with concomitant coro­nary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):45-52
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190
Surgical explantation of transcatheter aortic valve for para­prosthetic regu­rgitation and leaflet dege­neration. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):226-229
Abstract:

Aortic stenosis (AS) is the most common valvular disease in developed countries. Transcatheter aortic valve implantation (TAVI) is an efficient and safe procedure in the treatment of severe aortic stenosis with low risk of procedural complications. Indeed, accumulation of surgical experience has significantly reduced the incidence of procedural complications. However, high incidence of postoperative disorders of atrioventricular (AV) conduction is still a serious problem. This issue becomes even more important considering expansion of indications for TAVI in younger patients. This review is devoted to modern data on AV conduction disorders after TAVI and approaches to reducing the incidence of these complications.

Keywords:

aortic stenosis
transcatheter aortic valve implantation
cardiac conduction system
atrioventricular conduction disorder
atrioventricular blockade
pacemaker

Authors:

Baranov A.A.

Meshalkin National Medical Research Center

Krestyaninov O.V.

Meshalkin National Medical Research Center

Badoyan A.G.

Meshalkin National Medical Research Center

Khelimskii D.A.

Meshalkin National Medical Research Center

Manukyan S.N.

Meshalkin National Medical Research Center

Cydenova A.Yu.

Meshalkin National Medical Research Center

Naydenov R.A.

Meshalkin National Medical Research Center

Spiridonov A.A.

Meshalkin National Medical Research Center

Received:

03.03.2023

Accepted:

20.04.2023

Close metadata

References:

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005-1011. https://doi.org/10.1016/S0140-6736(06)69208-8
  2. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. JACC: Journal of the American College of Cardiology. 2013;62(11):1002-1012. https://doi.org/10.1016/j.jacc.2013.05.015
  3. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nature Reviews Cardiology. 2011;8(3):162-172.  https://doi.org/10.1038/nrcardio.2010.202
  4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England Journal of Medicine. 2010;363(17):1597-1607. https://doi.org/10.1056/NEJMoa1008232
  5. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. JACC: Journal of the American College of Cardiology. 2014;63(19):1972-1981. https://doi.org/10.1016/j.jacc.2014.02.556
  6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine. 2011;364(23):2187-2198. https://doi.org/10.1056/NEJMoa1103510
  7. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine. 2016;374(17):1609-1620. https://doi.org/10.1056/NEJMoa1514616
  8. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine. 2017;376(14):1321-1331. https://doi.org/10.1056/NEJMoa1700456
  9. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. New England Journal of Medicine. 2019;380(18):1695-1705. https://doi.org/10.1056/NEJMoa1814052
  10. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. New England Journal of Medicine. 2019;380(18):1706-1715. https://doi.org/10.1056/NEJMoa1816885
  11. Levack MM, Kapadia SR, Soltesz EG, Gillinov AM, Houghtaling PL, Navia JL, Krishnaswamy A, Blackstone EH, Svensson LG, Mick SL. Prevalence of and Risk Factors for Permanent Pacemaker Implantation After Aortic Valve Replacement. Annals of Thoracic Surgery. 2019;108(3):700-707.  https://doi.org/10.1016/j.athoracsur.2019.03.056
  12. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S. Open issues in transcatheter aortic valve implantation, part 2: procedural issues and outcomes after transcatheter aortic valve implantation. European Heart Journal. 2014;35:2639-2654. https://doi.org/10.1093/eurheartj/ehu257
  13. Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rodés-Cabau J, Szeto WY, Jilaihawi H, Fearon WF, Dvir D, Dewey TM, Makkar RR, Xu K, Di- zon JM, Smith CR, Leon MB, Kodali SK. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. European Heart Journal. 2014;35:1599-1607. https://doi.org/10.1093/eurheartj/eht376
  14. van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens L, Rodés-Cabau J, van Domburg RT, Serruys PW, Anderson RH, de Jaegere PP. New conduction abnormalities after TAVI — frequency and causes. Nature Reviews Cardiology. 2012;9:454-463.  https://doi.org/10.1038/nrcardio.2012.58
  15. Rampat R, Khawaja MZ, Hilling-Smith R, et al. Conduction abnormalities and permanent pacemaker implantation after transcatheter aortic valve replacement using the Repositionable LOTUS Device: the United Kingdom experience. JACC: Cardiovascular Interventions. 2017;10:1247-1253.
  16. De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implan- tation height. JACC: Cardiovascular Interventions. 2016;9:805-813.  https://doi.org/10.1016/j.jcin.2015.12.023
  17. Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC: Cardiovascular Interventions. 2016;9:244-254.  https://doi.org/10.1016/j.jcin.2015.09.036
  18. Finkelstein A, Steinvil A, Rozenbaum Z, Halkin A, Banai S, Barbash I, Guetta V, Segev A, Danenberg H, Orvin K, Assa HV, Assali A, Kornowski R. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry. Clinical Research in Cardiology. 2019;108(4):430-437.  https://doi.org/10.1007/s00392-018-1372-6
  19. Zaid S, Sengupta A, Okoli K, Tsoi M, Khan A, Ahmad H, Goldberg JB, Undemir C, Rozenshtein A, Patel N, Khan M, Gupta E, Kovacic J, Lansman SL, Dangas GD, Sharma SK, Kini A, Tang GHL. Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation. American Journal of Cardiology. 2020;125(8):1222-1229. https://doi.org/10.1016/j.amjcard.2020.01.008
  20. Massoullié G, Bordachar P, Ellenbogen KA, Souteyrand G, Jean F, Com- baret N, Vorilhon C, Clerfond G, Farhat M, Ritter P, Citron B, Lusson JR, Motreff P, Ploux S, Eschalier R. New-onset left bundle branch block induced by transcutaneous aortic valve implantation. American Journal of Cardiology. 2016;117:867-873.  https://doi.org/10.1016/j.amjcard.2015.12.009
  21. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Mau- genest AM, Cheng J, Piazza N, van Domburg RT, Serruys PW, de Jaegere PP. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. European Heart Journal. 2011;32:2067-2074. https://doi.org/10.1093/eurheartj/ehr110
  22. Testa L, Latib A, De Marco F, De Carlo M, Agnifili M, Latini RA, Petronio AS, Ettori F, Poli A, De Servi S, Ramondo A, Napodano M, Klugmann S, Us- sia GP, Tamburino C, Brambilla N, Colombo A, Bedogni F. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve im- plantation with CoreValve Revalving System. Circulation. 2013;127:1300-1307. https://doi.org/10.1161/CIRCULATIONAHA.112.001099
  23. Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence MS, Redwood S, Kahlert P, Rodes-Cabau J, Leipsic J, Webb J. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. EuroIntervention. 2016;12:e235-e243. https://doi.org/10.4244/EIJV12I2A37
  24. Houthuizen P, van der Boon RM, Urena M, Van Mieghem N, Brueren GB, Poels TT, Van Garsse LA, Rodés-Cabau J, Prinzen FW, de Jaegere P. Occurrence, fate and consequences of ventricular conduction abnor- malities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142-1150. https://doi.org/10.4244/EIJV9I10A194
  25. Auffret V, Puri R, Urena M, Chamandi C, Rodriguez-Gabella T, Philippon F, Rodés-Cabau J. Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives. Circulation. 2017;136(11):1049-1069. https://doi.org/10.1161/CIRCULATIONAHA.117.028352
  26. Schymik G, Tzamalis P, Bramlage P, Heimeshoff M, Würth A, Wondraschek R, Gonska BD, Posival H, Schmitt C, Schröfel H, Luik A. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clinical Research in Cardiology. 2015;104(4):351-362.  https://doi.org/10.1007/s00392-014-0791-2
  27. Faroux L, Chen S, Muntané-Carol G, Regueiro A, Philippon F, Sondergaard L, Jørgensen TH, Lopez-Aguilera J, Kodali S, Leon M, Nazif T, Rodés-Cabau J. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. European Heart Journal. 2020;41(29):2771-2781. https://doi.org/10.1093/eurheartj/ehz924
  28. Carrabba N, Valenti R, Migliorini A, Marrani M, Cantini G, Parodi G, Dovellini EV, Antoniucci D. Impact on Left Ventricular Function and Remodeling and on 1-Year Outcome in Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. American Journal of Cardiology. 2015;116(1):125-131.  https://doi.org/10.1016/j.amjcard.2015.03.054
  29. Nazif TM, Chen S, George I, Dizon JM, Hahn RT, Crowley A, Alu MC, Babaliaros V, Thourani VH, Herrmann HC, Smalling RW, Brown DL, Mack MJ, Kapadia S, Makkar R, Webb JG, Leon MB, Kodali SK. New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. European Heart Journal. 2019;40(27):2218-2227. https://doi.org/10.1093/eurheartj/ehz227
  30. Muntané-Carol G, Urena M, Nombela-Franco L, Amat-Santos I, Kleiman N, Munoz-Garcia A, Atienza F, Serra V, Deyell MW, Veiga-Fernandez G, Masson JB, Canadas-Godoy V, Himbert D, Castrodeza J, Elizaga J, Francisco Pascual J, Webb JG, de la Torre Hernandez JM, Asmarats L, Pelletier-Beaumont E, Philippon F, Rodés-Cabau J. Arrhythmic burden in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement: 2-year results of the MARE study. Europace. 2021;23(2):254-263.  https://doi.org/10.1093/europace/euaa213
  31. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, Puri R, Urena M, Philippon F, Rodés-Cabau J. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve re- placement: a systematic review and meta-analysis. Circulation: Cardiovascular Interventions. 2016;9:e003635. https://doi.org/10.1161/CIRCINTERVENTIONS.115.003635
  32. Hoffmann R, Herpertz R, Lotfipour S, Aktug Ö, Brehmer K, Lehmacher W, Autschbach R, Marx N, Lotfi S. Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC: Cardiovascular Interventions. 2012;5(12):1257-1263. https://doi.org/10.1016/j.jcin.2012.08.011
  33. Priesler O, Biner S, Finkelstein A, Michowitz Y. Conduction Abnormalities after Transcatheter Aortic Valve Implantation and Diastolic Dysfunction. Cardiology. 2017;137(1):36-42.  https://doi.org/10.1159/000452706
  34. Siontis GC, Jüni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B, Wenaweser P, Windecker S. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. JACC: Journal of the American College of Cardiology. 2014;64(2):129-140.  https://doi.org/10.1016/j.jacc.2014.04.033
  35. Meduri CU, Kereiakes DJ, Rajagopal V, Makkar RR, O’Hair D, Linke A, Waksman R, Babliaros V, Stoler RC, Mishkel GJ, Rizik DG, Iyer VS, Schindler J, Allocco DJ, Meredith IT, Feldman TE, Reardon MJ. Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial. Journal of the American Heart Association. 2019;8(21):e012594. https://doi.org/10.1161/JAHA.119.012594
  36. Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, Williams M, Guerrero M, Eisenhauer AC, Kapadia S, Kereiakes DJ, Herrmann HC, Babaliaros V, Szeto WY, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Blanke P, Whisenant BK, Suri RM, Makkar RR, Ayele GM, Svensson LG, Webb JG, Mack MJ, Smith CR, Leon MB. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. European Heart Journal. 2016;37(28):2252-2262. https://doi.org/10.1093/eurheartj/ehw112
  37. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. European Heart Journal. 2017;38(36):2717-2726. https://doi.org/10.1093/eurheartj/ehx294
  38. Nazif TM, Cahill TJ, Daniels D, McCabe JM, Reisman M, Chakravarty T, Makkar R, Krishnaswamy A, Kapadia S, Chehab BM, Wang J, Spies C, Rodriguez E, Kaneko T, Hahn RT, Leon MB, George I. Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States. Circulation: Cardiovascular Interventions. 2021;14(9):e010543. https://doi.org/10.1161/CIRCINTERVENTIONS.121.010543
  39. Saia F, Gandolfo C, Palmerini T, Berti S, Doshi SN, Laine M, Marcelli C, Piva T, Ribichini F, De Benedictis M, Cardaioli F, Cannata S, Tarantini G. In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry. EuroIntervention. 2020;15(14):1240-1247. https://doi.org/10.4244/EIJ-D-19-00541
  40. Forrest JK, Kaple RK, Tang GHL, Yakubov SJ, Nazif TM, Williams MR, Zhang A, Popma JJ, Reardon MJ. Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. JACC: Cardiovascular Interventions. 2020;13(2):170-179.  https://doi.org/10.1016/j.jcin.2019.08.035
  41. Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL 3rd, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC: Cardiovascular Interventions. 2018;11(2):160-168.  https://doi.org/10.1016/j.jcin.2017.10.014
  42. Lanz J, Kim WK, Walther T, Burgdorf C, Möllmann H, Linke A, Redwood S, Thilo C, Hilker M, Joner M, Thiele H, Conzelmann L, Conradi L, Kerber S, Schymik G, Prendergast B, Husser O, Stortecky S, Heg D, Jüni P, Windecker S, Pilgrim T; SCOPE I investigators. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619-1628. https://doi.org/10.1016/S0140-6736(19)32220-2
  43. Makkar RR, Cheng W, Waksman R, Satler LF, Chakravarty T, Groh M, Abernethy W, Russo MJ, Heimansohn D, Hermiller J, Worthley S, Chehab B, Cunningham M, Matthews R, Ramana RK, Yong G, Ruiz CE, Chen C, Asch FM, Nakamura M, Jilaihawi H, Sharma R, Yoon SH, Pichard AD, Kapadia S, Reardon MJ, Bhatt DL, Fontana GP. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet. 2020;396(10252):669-683.  https://doi.org/10.1016/S0140-6736(20)31358-1
  44. Komlev AE, Imaev TE, Kolegaev AS, Lepilin PM, Makeev MI, Akchurin RS. Results of new-generation self-expanding transcatheter Portico TM valve implantation in patients with degenerative aortic stenosis. Kardiologiia. 2022;62(8):45-51. (In Russ.). https://doi.org/10.18087/cardio.2022.8.n1923
  45. Imaev TE, Komlev AE, Lepilin PM, Kolegaev AS, Salichkin DV, Kuchin IV, Akchurin RS. First experience of transcatheter implantation of new-generation self-expanding bioprosthesis Acurate neo. Russian Journal of Cardiology. 2019;(8):59-64. (In Russ.). https://doi.org/10.15829/1560-4071-2019-8-59-64
  46. Krestyaninov OV, Baranov AA, Ibragimov RU, Khelimskii DA, Badoyan AG, Gorgulko AP, Utegenov RB. In-hospital outcomes of transcatheter aortic valve implantation procedure: data of single-center registry. Siberian Journal of Clinical and Experimental Medicine. 2022;37(2):49-56. (In Russ.). https://doi.org/10.29001/2073-8552-2022-37-2-49-56
  47. Urena M, Webb JG, Tamburino C, Muñoz-García AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Briales JH, Benitez LM, Al Lawati H, Cucalon AM, García Del Blanco B, López J, Dumont E, Delarochellière R, Ribeiro HB, Nombela-Franco L, Philippon F, Rodés-Cabau J. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129(11):1233-1243. https://doi.org/10.1161/CIRCULATIONAHA.113.005479
  48. Junquera L, Freitas-Ferraz AB, Padrón R, Silva I, Nunes Ferreira-Neto A, Guimaraes L, Mohammadi S, Morís C, Philippon F, Rodés-Cabau J. Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances. Catheterization and Cardiovascular Interventions. 2020;95(5):982-990.  https://doi.org/10.1002/ccd.28323
  49. Nazif TM, Chen S, Kodali SK. Disarming the Ticking Time Bomb: Post-Procedure Electrocardiography Predictors of High-Degree Conduction Disturbances After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2018;11(15):1527-1530. https://doi.org/10.1016/j.jcin.2018.07.003
  50. García E, Martín P, Hernández R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C. Feasibility and safety of transfemoral implanta- tion of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve. Catheterization and Cardiovascular Interventions. 2014;83:791-795.  https://doi.org/10.1002/ccd.24766
  51. Bernardi FL, Ribeiro HB, Carvalho LA, Sarmento-Leite R, Mangione JA, Lemos PA, Abizaid A, Grube E, Rodés-Cabau J, de Brito FS Jr. Direct Transcatheter Heart Valve Implantation Versus Implantation With Balloon Predilatation: Insights From the Brazilian Transcatheter Aortic Valve Replacement Registry. Circulation: Cardiovascular Interventions. 2016;9(8):e003605. https://doi.org/10.1161/CIRCINTERVENTIONS.116.003605
  52. Campelo-Parada F, Nombela-Franco L, Urena M, Regueiro A, Jiménez-Quevedo P, Del Trigo M, Chamandi C, Rodríguez-Gabella T, Auffret V, Abdul-Jawad Altisent O, DeLarochellière R, Paradis JM, Dumont E, Philippon F, Pérez-Castellano N, Puri R, Macaya C, Rodés-Cabau J. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty. Revista Española de Cardiología. 2018;71(3):162-169. English, Spanish. https://doi.org/10.1016/j.rec.2017.04.010
  53. Benetos G, Karmpalioti M, Drakopoulou M, Stathogiannis K, Xanthopoulou M, Latsios G, Synetos A, Bei E, Voudris V, Iakovou I, Katsimagklis G, Moraitis S, Zeniou V, Danenberg H, Halvatsiotis P, Vavuranakis M, Tousoulis D, Toutouzas K. One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve. Catheterization and Cardiovascular Interventions. 2021;98(3):E403-E411. https://doi.org/10.1002/ccd.29389
  54. Pascual I, Hernández-Vaquero D, Alperi A, Almendarez M, Avanzas P, Kalavrouziotis D, Lorca R, Mesnier J, Arboine L, Mohammadi S, Valle RD, Dumont E, Leon V, De Larochelliere R, Rodés-Cabau J, Moris C. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis. JACC: Cardiovascular Interventions. 2022;15(2):150-161.  https://doi.org/10.1016/j.jcin.2021.10.002
  55. Ben-Shoshan J, Alosaimi H, Lauzier PT, Pighi M, Talmor-Barkan Y, Overtchouk P, Martucci G, Spaziano M, Finkelstein A, Gada H, Piazza N. Double S-Curve Versus Cusp-Overlap Technique: Defining the Optimal Fluoroscopic Projection for TAVR With a Self-Expanding Device. JACC: Cardiovascular Interventions. 2021;14(2):185-194.  https://doi.org/10.1016/j.jcin.2020.10.033
  56. Jilaihawi H, Zhao Z, Du R, Staniloae C, Saric M, Neuburger PJ, Querijero M, Vainrib A, Hisamoto K, Ibrahim H, Collins T, Clark E, Pushkar I, Bamira D, Benenstein R, Tariq A, Williams M. Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2019;12(18):1796-1807. https://doi.org/10.1016/j.jcin.2019.05.056
  57. Pascual I, Almendárez M, Avanzas P, Álvarez R, Arboine LA, Del Valle R, Hernández-Vaquero D, Alfonso F, Morís C. Cusp-overlapping TAVI technique with a self-expanding device optimizes implantation depth and reduces permanent pacemaker requirement. Revista Española de Cardiología. 2022;75(5):412-420.  https://doi.org/10.1016/j.rec.2021.05.009
  58. Tretter JT, Mori S, Anderson RH, Taylor MD, Ollberding N, Truong V, Choo J, Kereiakes D, Mazur W. Anatomical predictors of conduction damage after transcatheter implantation of the aortic valve. Open Heart. 2019;6(1):e000972. https://doi.org/10.1136/openhrt-2018-000972
  59. Kiani S, Kamioka N, Black GB, Lu MLR, Lisko JC, Rao B, Mengistu A, Gleason PT, Stewart JP, Caughron H, Dong A, Patel H, Grubb KJ, Greenbaum AB, Devireddy CM, Guyton RA, Leshnower B, Merchant FM, El-Chami M, Westerman SB, Lloyd MS, Babaliaros VC, Hoskins MH. Development of a Risk Score to Predict New Pacemaker Implantation After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2019;12(21):2133-2142. https://doi.org/10.1016/j.jcin.2019.07.015
  60. Alperi Garcia A, Muntané-Carol G, Junquera L, Del Val D, Faroux L, Philippon F, Rodés-Cabau J. Can we reduce conduction disturbances following transcatheter aortic valve replacement? Expert Review of Medical Devices. 2020;17(4):309-322.  https://doi.org/10.1080/17434440.2020.1741349
  61. Lilly SM, Deshmukh AJ, Epstein AE, Ricciardi MJ, Shreenivas S, Velagapudi P, Wyman JF. 2020 ACC Expert Consensus Decision Pathway on Management of Conduction Disturbances in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report of the American College of Cardiology Solution Set Oversight Committee. JACC: Journal of the American College of Cardiology. 2020;76(20):2391-2411. https://doi.org/10.1016/j.jacc.2020.08.050
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.